The risks and benefits of bisphosphonate therapy in moderate-severe (stage 3B+) chronic kidney disease: a propensity-score matched cohort study
Health Technology Assessment(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Health Technology Assessment(2019)